BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Columbus McKinnon
CMCO
$584M
| $80.6M | ﹤0.01% |
2,333,898
-20,238
| -0.9% | -$821K |
|
2152
PUT
Merck
MRK
$318B
| $80.6M | ﹤0.01% |
+651,000
| New | +$83.9M |
|
2153
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
| $80.2M | ﹤0.01% |
1,865,265
-10,101
| -0.5% | -$435K |
|
2154
Arcutis Biotherapeutics
ARQT
$3.18B
| $80.2M | ﹤0.01% |
8,622,618
+1,963,877
| +29% | +$17.8M |
|
2155
Usana Health Sciences
USNA
$286M
| $80.1M | ﹤0.01% |
1,770,198
-47,524
| -3% | -$2.19M |
|
2156
TriMas Corp
TRS
$1.44B
| $80.1M | ﹤0.01% |
3,132,560
-27,274
| -0.9% | -$717K |
|
2157
Independent Bank Corp
IBCP
$844M
| $80M | ﹤0.01% |
2,963,583
+146,816
| +5% | +$3.63M |
|
|
NVO
2158
CALL
Novo Nordisk
NVO
$209B
| $79.9M | ﹤0.01% |
560,000
-560,000
| -50% | -$74.2M |
|
2159
Genco Shipping & Trading
GNK
$1.1B
| $79.9M | ﹤0.01% |
3,750,636
+327,532
| +10% | +$7.05M |
|
2160
Prothena Corp
PRTA
$450M
| $79.6M | ﹤0.01% |
3,857,079
+138,266
| +4% | +$2.99M |
|
2161
SiriusXM
SIRI
$10.1B
| $79.4M | ﹤0.01% |
2,807,253
-1,571,471
| -36% | -$46.9M |
|
2162
Cadre Holdings
CDRE
$1.41B
| $79.4M | ﹤0.01% |
2,364,769
+580,183
| +33% | +$19.1M |
|
2163
indie Semiconductor
INDI
$854M
| $79.3M | ﹤0.01% |
12,846,499
+1,768,536
| +16% | +$11.2M |
|
2164
Enact Holdings
ACT
$6.73B
| $79.2M | ﹤0.01% |
2,582,992
+54,341
| +2% | +$1.66M |
|
2165
Sociedad Química y Minera de Chile
SQM
$20.6B
| $79.1M | ﹤0.01% |
1,940,107
-404,859
| -17% | -$18.7M |
|
2166
Amalgamated Financial
AMAL
$1.49B
| $79M | ﹤0.01% |
2,884,975
+117,103
| +4% | +$2.86M |
|
|
THR
2167
DELISTED
Thermon Group Holdings
THR
| $79M | ﹤0.01% |
2,569,409
+25,303
| +1% | +$811K |
|
|
TRST
2168
Trustco Bank Corp NY
TRST
$938M
| $78.9M | ﹤0.01% |
2,742,750
-49,022
| -2% | -$1.35M |
|
2169
Ocular Therapeutix
OCUL
$2.02B
| $78.8M | ﹤0.01% |
11,520,326
+3,456,623
| +43% | +$21.3M |
|
2170
Diebold Nixdorf
DBD
$2.56B
| $78.7M | ﹤0.01% |
2,045,655
+1,378,862
| +207% | +$52.5M |
|
|
DX
2171
Dynex Capital
DX
$3.21B
| $78.5M | ﹤0.01% |
6,576,387
+483,718
| +8% | +$5.81M |
|
2172
Liberty Live Group Series C
LLYVK
$9.46B
| $78.1M | ﹤0.01% |
2,041,945
+60,668
| +3% | +$2.35M |
|
2173
Reynolds Consumer Products
REYN
$5.59B
| $77.7M | ﹤0.01% |
2,778,329
+13,425
| +0.5% | +$382K |
|
2174
Herbalife
HLF
$1.29B
| $77.6M | ﹤0.01% |
7,472,139
+264,462
| +4% | +$2.64M |
|
2175
CEVA Inc
CEVA
$1.08B
| $77.4M | ﹤0.01% |
4,012,119
-87,681
| -2% | -$1.78M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,440 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.